The recent credit crisis and slowing economy have resulted in an increase in distressed mergers and acquisitions (M&A) transactions. In this timely program, Foley attorneys Steven H. Hilfinger, Daljit S. Doogal, and Geoffrey S. Goodman, along with Miller Buckfire & Co. Director Alexander Tracy, discuss the issues, opportunities, and challenges both sellers and buyers face in distressed M&A transactions. Topics included:
- Should a transaction be effectuated in or out of bankruptcy?
- If in bankruptcy, should the transaction be consummated under a plan or as a Section 363 sale?
- What are the threshold considerations facing various constituencies, including the buyer, seller, senior lenders, junior creditors, and other stakeholders?
- Given today’s credit climate, what alternatives are available for financing a distressed M&A transaction?
- What critical issues should be addressed in the purchase agreement?
For additional information about Foley’s M&A Briefing Series, please contact Jackie Polson at [email protected].
People
Related Insights
09 May 2024
Events
The FTC Noncompete Rule: Where Do We Go From Here?
On Tuesday, April 23, 2024, the Federal Trade Commission (FTC) voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Article
FTC Finalizes Rule Against Employee Noncompetes
On April 23, 2024, the Federal Trade Commission voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Health Care Law Today
FDA Continues to Take Stance That it Will Not Issue CBD Rules
The FDA recently doubled down on its January 26, 2023 position that existing regulatory pathways for foods and dietary supplements are not appropriate to manage the risks of CBD and a new regulatory pathway is needed.